Intelligent Bio Solutions (INBS) Equity Income (2022 - 2023)
Intelligent Bio Solutions' quarterly Equity Income came in at $44488.0 in Q4 2023, down 97.52% year-on-year from $1.8 million in Q4 2022, and down 66.1% quarter-over-quarter from $131250.0 in Q3 2023.
Intelligent Bio Solutions has reported Equity Income for 2 years, with the latest figure at $44488.0 in Q4 2023.
- For the quarter ending Q4 2023, Equity Income fell 97.52% year-over-year to $44488.0; the trailing twelve-month figure through Mar 2024 stood at $267225.0 (changed N/A YoY), and the FY2023 full-year result was $2.2 million, changed N/A from the prior year.
- Equity Income for Q4 2023 stood at $44488.0, down from $131250.0 in the prior quarter.
- The five-year high for Equity Income was $1.8 million in Q4 2022, with the low at $44488.0 in Q4 2023.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Equity Income (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | - |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | - |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | - |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | - |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | - |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | - |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | - |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | - |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | - |
| 10 | Intelligent Bio Solutions | 13.61 Mn | 12.40 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2023 | 44,488.00 |
| Sep 30, 2023 | 131,250.00 |
| Jun 30, 2023 | 91,487.00 |
| Mar 31, 2023 | 269,787.00 |
| Dec 31, 2022 | 1.79 Mn |